Factors Associated With Biologic Therapy After Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis
Inflammatory Bowel Diseases · 07.07.2025 · 31 (7) · 1934-1942
DOI: 10.1093/ibd/izae272 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 14.11.2024. Verfasst von Maya Fischman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Military Medicine, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Proctocolectomy, Restorative, Biological Therapy, Colonic Pouches. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: The Leona M. and Harry B. Helmsley Charitable Trust.
Abstract (Originalsprache)
Background
Patients with ulcerative colitis (UC) undergoing proctocolectomy and ileal pouch–anal anastomosis (IPAA) may eventually require biologic therapy. Factors associated with biologic therapy after IPAA have not been previously studied.
Methods
All patients with UC after total proctocolectomy and IPAA who were followed at Rabin Medical Center comprehensive pouch clinic and who consented to prospective observational follow-up were included. The primary outcome was the initiation of biologic therapy after IPAA. Cox proportional hazard models were used to evaluate potential associations.
Results
Out of 400 patients receiving their care at the pouch clinic, 148 patients consented to prospective observational follow-up and constituted the study cohort. The median age at diagnosis was 21 years and the age at IPAA was 30 years. Median time-to-biologic therapy initiation post-IPAA was 9.2 years, with 34 patients (23%) initiating biologic therapy: Associated factors for initiating biologic therapy post-IPAA were preoperative treatment with biologic therapy and immunomodulatory therapy (hazard ratio [HR] 6.1 and 3.6, respectively, P < .001); Arab descent (HR 5.3, P < .001); heterozygosity of NOD2 variant rs2066845 (HR 5.1, P = .03); past smoking status (HR 2.3, P = .03); 3-stage IPAA (HR 2.3, P = .02); immediate postoperative complications (HR 2.1, P = .033); and pediatric-onset UC (HR 2.1, P = .03). None of the patients undergoing IPAA due to dysplasia (n = 27) required biologic therapy.
Conclusions
Several demographic, disease-related, surgery-related, and genetic factors associated with post-IPAA biologic therapy were identified. Physicians treating patients with UC undergoing colectomy should incorporate these factors into their decision-making process. These patients may benefit from closer postoperative follow-up, and earlier initiation of biologic therapy should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Military Medicine, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
- Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Division of Surgery, Rabin Medical Center, Petah-Tikva, Israel.
- Felsenstein Medical Research Center, Rabin Medical Center, Tel Aviv University, Petah-Tikva, Israel.
ORCID-Profile: Maya Fischman, Lihi Godny, Henit Yanai, Jacob E Ollech
Förderung
- The Leona M. and Harry B. Helmsley Charitable Trust
Zitieren
APA
Fischman, M., Godny, L., Friedenberg, A., Barkan, R., White, I., Wasserberg, N., Rabinowitz, K., Avni-Biron, I., Banai, H., Snir, Y., Broitman, Y., Yanai, H., Dotan, I., & Ollech, J. E. (2025). Factors Associated With Biologic Therapy After Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis. Inflammatory Bowel Diseases, 31(7), 1934-1942. https://doi.org/10.1093/ibd/izae272
Vancouver
Fischman M, Godny L, Friedenberg A, Barkan R, White I, Wasserberg N, et al. Factors Associated With Biologic Therapy After Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis. Inflammatory Bowel Diseases. 2025;31(7):1934-1942. doi:10.1093/ibd/izae272
BibTeX
@article{Fischman2025,
author = {Fischman, Maya and Godny, Lihi and Friedenberg, Adi and Barkan, Revital and White, Ian and Wasserberg, Nir and Rabinowitz, Keren and Avni-Biron, Irit and Banai, Hagar and Snir, Yifat and Broitman, Yelena and Yanai, Henit and Dotan, Iris and Ollech, Jacob E},
title = {Factors Associated With Biologic Therapy After Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis},
journal = {Inflammatory Bowel Diseases},
year = {2025},
volume = {31},
number = {7},
pages = {1934--1942},
doi = {10.1093/ibd/izae272}
}
EUVIMED